The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety

EuroIntervention 2010;6:498-504.

Ben J.L. Van den Branden
Ben J. Van den Branden*, MD; Justin G. Luermans, MD, PhD; Martijn C. Post, MD, PhD; Herbert W. Plokker, MD, PhD; Jurriën M. ten Berg, MD, PhD; Maarten J. Suttorp, MD, PhD
Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands

Aims: To compare the mid-term efficacy and safety of the bioabsorbable BioSTAR® device with the non-bioabsorbable CardioSEAL® dev

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

transcatheter closurepatent foramen ovaleresidual shunt
Share on Facebook Share on Twitter Share on Linkedin
Read next article
The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach

Latest news

NEW ISSUE
CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR
August 7, 2020
NEW
Ahead of Print: Coronary Artery Thrombosis in COVID-19
August 7, 2020
Editorial
Coronary collaterals, the natural grafts of CTO lesions
C. Di Mario
August 7, 2020
TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more
(The Trials book is supported by Biotronik)
August 5, 2020
Guidance Papers
Guidelines, consensus & position papers
June 25, 2020
Editorial
Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success
JM De la Torre Hernandez
August 7, 2020
JAA
This Week's JAA's: Real-world Use of the Evolut PRO Valve...
August 4, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke